Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
abrdn Life Sciences Investors (HQL) had Cash Flow from Financial Activities of $-10.63M for the most recently reported fiscal quarter, ending 2007-09-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$0.30M |
|
-- |
|
$308.77M |
|
$309.07M |
|
$0.51M |
|
-- |
|
$0.56M |
|
$1.08M |
|
$308.00M |
|
$307.99M |
|
$307.99M |
|
-- |
|
| Cash Flow Statement Financials | |
$10.63M |
|
$0.00M |
|
|
Cash Flow from Financial Activities |
$-10.63M |
$0.00M |
|
$0.00M |
|
$-0.00M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|